{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/NNNN",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Anbio Biotechnology (NASDAQ: NNNN) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Anbio Biotechnology, listed on NASDAQ under ticker NNNN, with ISIN USG0367B1055. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-E9 exists. The security type is Non-operating entity type (other), the segment is not on the record, the sector is 2835 In Vitro & In Vivo Diagnostic Substances, and the jurisdiction is Cayman Islands. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 16 filings in the window from 2025-11-08 to 2026-11-08, across 11 filing days: 7 directors' dealings, 1 prospectus and 8 results. The median gap between filing days is 23.0 days. The latest filing is a prospectus dated 2026-07-09, which is 122 days before the record date of 2026-11-08. The exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4359 issuers. The sector median is 61 filings, a cadence gap of 6.5 days and a latency of 4 days across 19 issuers.\n\n## Auditor\n\nThe auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The location is not on the record, and the record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page, and the count is 0.\n\n## Open research\n\nNo openly published research notes were found, and the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer is held in sealed years 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001982708.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/NNNN (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/NNNN (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/NNNN",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 19,
     "median_cadence_gap_days": 6.5,
     "median_filings": 61,
     "median_latency_days": 4,
     "name": "2835 In Vitro & In Vivo Diagnostic Substances"
    }
   },
   "by_type": {
    "directors_dealings": 7,
    "prospectus": 1,
    "results": 8
   },
   "cadence_median_gap_days": 23,
   "filing_days": 11,
   "filings": 16,
   "latency_days": 122,
   "latest": [
    {
     "category": "F-3ASR",
     "date": "2026-07-09",
     "source": "https://www.sec.gov/Archives/edgar/data/1982708/000118518526002869/anbiof3asr070226.htm",
     "title": "F-3ASR — AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU",
     "type": "prospectus"
    },
    {
     "category": "3",
     "date": "2026-06-12",
     "source": "https://www.sec.gov/Archives/edgar/data/1982708/000118518526002487/xslF345X06/ownership.xml",
     "title": "3",
     "type": "directors_dealings"
    },
    {
     "category": "3",
     "date": "2026-06-12",
     "source": "https://www.sec.gov/Archives/edgar/data/1982708/000118518526002486/xslF345X06/ownership.xml",
     "title": "3",
     "type": "directors_dealings"
    },
    {
     "category": "6-K",
     "date": "2026-05-19",
     "source": "https://www.sec.gov/Archives/edgar/data/1982708/000118518526001897/anbio6k051826.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    },
    {
     "category": "6-K",
     "date": "2026-04-27",
     "source": "https://www.sec.gov/Archives/edgar/data/1982708/000118518526001504/anbio6k042226.htm",
     "title": "6-K — FORM 6-K",
     "type": "results"
    }
   ],
   "latest_filing_date": "2026-07-09",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/NNNN",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "USG0367B1055"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001982708.json",
    "state": "sourced",
    "value": "Cayman Islands"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-E9",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001982708.json",
    "state": "sourced",
    "value": "Anbio Biotechnology"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001982708.json",
    "state": "sourced",
    "value": "2835 In Vitro & In Vivo Diagnostic Substances"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001982708.json",
    "state": "sourced",
    "value": "Non-operating entity type (other)"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NNNN"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:0875a473a6c761924bc743c05da10cc9c6d16dadebb262c915eb1df9a0fe8103",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/NNNN",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:0875a473a6c761924bc743c05da10cc9c6d16dadebb262c915eb1df9a0fe8103",
 "path": "/us/NASDAQ/NNNN",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Anbio Biotechnology, listed on NASDAQ under ticker NNNN, with ISIN USG0367B1055. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-E9 exists. The security type is Non-operating entity type (other), the segment is not on the record, the sector is 2835 In Vitro & In Vivo Diagnostic Substances, and the jurisdiction is Cayman Islands. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 16 filings in the window from 2025-11-08 to 2026-11-08, across 11 filing days: 7 directors' dealings, 1 prospectus and 8 results. The median gap between filing days is 23.0 days. The latest filing is a prospectus dated 2026-07-09, which is 122 days before the record date of 2026-11-08. The exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days across 4359 issuers. The sector median is 61 filings, a cadence gap of 6.5 days and a latency of 4 days across 19 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The location is not on the record, and the record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page, and the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found, and the count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer is held in sealed years 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001982708.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/NNNN"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/NNNN"
  }
 ],
 "title": "Anbio Biotechnology (NNNN) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}